Cite Score:
0.7
CITE SCORE SCOPUS

Molecular Detection of Macrolide and Lincosamide-Resistance Genes in Clinical Methicillin-Resistant Staphylococcus aureus Isolates from Kerman, Iran

AUTHORS

Yasser Fasihi 1 , Fereshteh Saffari 1 , Mohammad Reza Kandehkar Ghahraman 1 , Davood Kalantar-Neyestanaki 1 , *

1 Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

How to Cite: Fasihi Y, Saffari F, Kandehkar Ghahraman M R, Kalantar-Neyestanaki D. Molecular Detection of Macrolide and Lincosamide-Resistance Genes in Clinical Methicillin-Resistant Staphylococcus aureus Isolates from Kerman, Iran, Arch Pediatr Infect Dis. 2017 ; 5(1):e37761. doi: 10.5812/pedinfect.37761.

ARTICLE INFORMATION

Archives of Pediatric Infectious Diseases: 5 (1); e37761
Published Online: July 18, 2016
Article Type: Research Article
Received: March 11, 2016
Revised: May 18, 2016
Accepted: June 6, 2016
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Staphylococcus aureus is a common pathogen in hospitals and communities. Antibiotic resistance is a major public health problem.

Objectives: The aim of this study was the determination of antimicrobial susceptibility patterns and to perform molecular detection of macrolide and lincosamide-resistance genes in clinical S. aureus isolates from Kerman, Iran.

Methods: From February 2014 to December 2015, a total of 170 clinical S. aureus isolates were obtained. Resistance to different antibiotics was determined by the disk diffusion method. Methicillin-resistant S. aureus (MRSA) and inducible clindamycin resistance were confirmed by phenotypic methods, and polymerase chain reaction (PCR) was used to detect the nuc, mecA, ermA, ermB, ermC, and mrsA/B genes.

Results: All isolates were sensitive to linezolid and vancomycin. In total, more than 50% of the isolates were multidrug resistant (MDR) and 52.5% were MRSA. Inducible clindamycin resistance was observed in 12.5% of the isolates. The prevalences of the mecA, ermA, ermB, ermC, and mrsA/B genes in the isolates were 39.5% (69/170), 11% (19/170), 3.5% (6/170), 20.5% (35/170), and 10.5% (18/170), respectively.

Conclusions: A high prevalence of macrolide and lincosamide-resistant genes were found in S. aureus isolates from nosocomial and community-acquired infections in Kerman, Iran. The investigation of antibiotic resistance may provide crucial information about the control of such infections, and it is necessary to accurately identify antibiotic resistance on routine susceptibility tests.

Keywords

MRSA Inducible Clindamycin Resistance erm Gene

Copyright © 2016, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Staphylococcus aureus is one of the most common causes of human nosocomial and community-acquired infections (1, 2). The emergence of antibiotic-resistant isolates, especially methicillin-resistant S. aureus (MRSA), poses a major problem for public health (3, 4). In the past few decades, the number of macrolide, lincosamide, and streptogramin (MLS)-resistant isolates associated with MRSA has increased in Iran and worldwide (2, 3). Several genes, including erm(A,B,C) and msr(A/B) are involved in the resistance to macrolides and lincosamides in S. aureus strains (1, 5, 6). erm gene production of methyltransferase enzymes and methylation of the ribosomal target site by methyltransferases causes inhibition of the binding of macrolides to the target site (1, 5). Active efflux by mrs(A/B) is the other mechanism of resistance to macrolides (1, 5).

2. Objectives

Erythromycin and clindamycin are used for the treatment of staphylococcal infections, such as skin and soft-tissue infections, and as alternatives in penicillin-allergic patients (3). Therefore, the aim of this study was the molecular detection of macrolide and lincosamide-resistance genes, including erm(A), erm(B), erm(C), and mrs(A/B), in clinical MRSA isolates from Kerman, Iran.

3. Methods

3.1. Bacterial Isolates

In this cross-sectional study, a total of 170 clinical isolates of S. aureus were collected from 145 inpatients and 25 outpatients at Kerman university-affiliated hospitals from February 2014 to December 2015. Bacterial isolates were identified by standard and biochemical methods, such as gram staining, catalase production, coagulase, DNase reaction, and mannitol fermentation. All of the applied culture media were purchased from Merck Co., Germany. Isolates were confirmed by detection of the nuc gene (4).

3.2. Antibiotic Susceptibility Testing

The antimicrobial susceptibility of isolates to gentamicin (10 µg), amikacin (30 µg), erythromycin (15 µg), clindamycin (2 µg), tetracycline (30 µg), ciprofloxacin (5 µg), trimethoprim/sulfamethoxazole (1.25/23.75 µg), linezolid (30 µg), and vancomycin (vancomycin-resistance screening was done with dilution methods) was determined according to the clinical and laboratory standards institute (CLSI) guidelines (7). S. aureus ATCC 25923 was used as the standard for antibiograms. Isolates resistant to at least three antibiotics from different classes were considered multidrug-resistant (MDR) according to the recommendations of Magiorakos et al. (8). All of the applied antibiotic disks were purchased from Mast, Inc.

3.3. Detection of MRSA

Susceptibility to cefoxitin (30 µg) (Mast Co.) was used for determination of MRSA isolates; they were then examined for the mec(A) gene (9).

3.4. Detection of Inducible Clindamycin Resistance

Inducible clindamycin resistance was determined with the D-zone test according to the CLSI guidelines (9).

3.5. Detection of Macrolide Resistance Genes by PCR

Total DNA was extracted by the boiling method (10). For erythromycin and clindamycin-resistant isolates, the resistance genes, including erm(A), erm(B), erm(C), and mrs(A/B) were detected by the PCR method using specific oligonucleotide primers (Table 1). PCR reactions were performed in the FlexCycler2 PCR thermal cycler (Analytik Jena) using PCR master mix (Ampliqon Inc., Denmark). S. aureus strains harboring mecA, erm(A), erm(B), erm(C), and mrs(A/B) were used as positive controls for PCR. These strains were received from Dr. Mohammad Emaneini (department of microbiology, school of medicine, Tehran University of Medical Sciences, Tehran, Iran) (11). PCR reactions were performed in total volumes of 25 μl. The master mix contained 12.5 µL of reaction mixture with Taq DNA polymerase master mix red (Ampliqon), 0.5 µL of each of the forward and reverse primers in 10 Pmol concentrations, 2 µL of target DNA, and 9.5 μl of distilled water. The PCR mixtures were subjected to 5 minutes at 96°C, followed by 30 cycles of 45 seconds at 95°C for denaturation, 45 seconds for annealing extension (Table 1), extension at 72°C for 2 minutes, and a final extension step at 72°C for 5 minutes. The PCR products were revealed by electrophoresis on a 1.5% agarose gel and subsequent exposure to UV light in the presence of DNA Green Viewer (Pars Tous Biotechnology, Iran) load dye.

Table 1. Primers Used in This Study
Gene TargetPrimer Sequence, 5’ - 3’Annealing Temperature, °CProduct Size, bpReference
nuc60279(4)
FGCG ATT GAT GGT GAT ACG GTT
RAGC CAA GCC TTG ACG AAC TAA AGC
mec(A)56162(10)
FTCC AGA TTA CAA CTT CAC CAG G
RCCA CTT CAT ATC TTG TAA CG
erm(A)56.5139(12)
FTAT CTT ATC GTT GAG AAG GGA TT
RCTA CAC TTG GCT TAG GAT GAA A
erm(B)56.5142(1)
FCTA TCT GAT TGT TGA AGA AGG ATT
RGTT TAC TCT TGG TTT AGG ATG AAA
erm(C)55.5297(13)
FAAT CGT CAA TTC CTG CAT GT
RTAA TCG TGG AAT ACG GGT TTG
mrs(A/B)56.5402(14)
FGCA AAT GGT GTA GGT AAG ACA ACT
RATC ATG TGA TGT AAA CAA AAT

3.6. Statistical Analysis

Statistical analysis was performed with SPSS (v.22.0) statistical software. We used the χ2 test for comparisons between the presence of mec(A) (MRSA isolates) and the macrolide and lincosamide-resistance genes. Differences were considered statistically significant at P-values of < 0.05.

4. Results

Out of a total of 170 S. aureus isolates, 85% (n = 145) were recovered from inpatients and 15% (n = 25) were recovered from outpatients. All of the isolates were sensitive to linezolid and vancomycin. The susceptibility test results for the other antibiotics are presented in Table 2. More than 50% of the isolates were MDR, of which 52.5% (89/170) were MRSA. Inducible clindamycin resistance was observed in 12.5% (21/170) of the isolates. The mecA, ermA, ermB, ermC, and mrsA/B genes were detected in 39.5% (69/170), 11% (19/170), 3.5% (6/170), 20.5% (35/170), and 10.5% (18/170) of the isolates, respectively. The distribution of MRSA, the inducible clindamycin resistance phenotypes and the presence of mecA, ermA, ermB, ermC and mrsA/B genes among the isolates from outpatients and inpatients are shown in Tables 3 and 4. Approximately 53% (90/170) of the isolates carried at least one of the erm (A,B,C) and/or mrs (A/B) genes. In this study, a significant correlation (P < 0.05) was observed between the presence of the mec (A) gene with the carriage of erm and mrs genes (Table 4). The rate of the erm and mrs resistance genes associated with mec (A) was 76/8% (53/69)

Table 2. Antibacterial Resistance Pattern of S. aureus Isolates Recovered from Outpatients and Inpatients in Kerman, Irana
Type of IsolateRate of Resistance to Antimicrobial Agents
Isolates, No.AKGMCDECIPTTSVALZD
Inpatient 14548 (33)59 (40.5)69 (47.5)81 (55.8)75 (52)94 (65)46 (32)0 (0)0 (0)
Outpatient 254 (16)9 (36)9 (36)13 (52)8 (32)12 (48)8 (32)0 (0)0 (0)
Total17052 (30.5)68 (40)78 (45.8)94 (55.5)83 (48.8)106 (63)54 (31.8)0 (0)0 (0)

Abbreviation: AK, amikacin; CD, clindamycin; CIP, ciprofloxacin; E, erythromycin; GM, gentamicin; LZD, linezolid; T, tetracycline; TS, trimethoprim/sulfamethoxazole; VA, vancomycin.

aValues are expressed as No. (%) unless otherwise indicated.

Table 3. Distribution of MRSA, Inducible Clindamycin Resistance (D-Test Positive), and mec(A), erm(A), erm(B), erm(C) and mrs(A/B) genes among S. aureus isolates from outpatients and inpatients
Isolates PatientsIsolates, No.MRSAD-test positive mec(A)erm(A)erm(B)erm(C)mrs(A/B)
Inpatient14582 (56.5)19 (13)63 (43.5)18 (12.5)6 (4.5)31 (21.5)11 (7.6)
Outpatient257 (28)2 (8)6 (24)1 (4)0 (0)4 (16)7 (28)
Total17089(52.5)21 (12.5)69 (39.5)19 (11)6 (3.5)35 (20.5)18 (10.5)
Table 4. Distribution Co-Existence of mec(A), Inducible Clindamycin Resistance (D-Test Positive), and erm(A), erm(B), erm(C), and mrs(A/B) Genes Among Clinical Isolates of S. aureus.
Pattern of Resistance Genes Number of Isolates
OutpatientInpatient
D-test positive12
mec (A)2-
mec(A) + D-test positive-5
D-test positive + erm(C)1-
mec(A) + erm(C)29
mec(A) + erm(A)-4
mec(A) + erm(B)-2
mec(A) + mrs(A/B)-4
mec(A) + D-test positive + erm(A)-1
mec(A) + D-test positive + erm(C)-2
mec(A) + erm(A) + erm(C)19
mec(A) + erm(C) + mrs(A/B)14
mec(A) + D-test positive + erm(B) + erm(C)-1
mec(A) + D-test positive + erm(A) + erm(B)-1
mec(A) + D-test positive + erm(C) + mrs(A/B)-2
mec(A) + erm(A) + erm(B) + erm(C)-1
Total847
Figure 1. D-Zone Showing Inducible Clindamycin Resistance
D-Zone Showing Inducible Clindamycin Resistance

A, erythromycin; B, clindamycin.

5. Discussion

Based on the results of this study, the prevalence of S. aureus resistance to macrolides and lincosamides was high in Kerman, Iran. In recent years, the number of infections with S. aureus, especially MRSA macrolide and lincosamide-resistant isolates have increased in our country and worldwide (4, 6, 12-16). In the present study, the highest resistance rates were observed for tetracycline, erythromycin, and ciprofloxacin, respectively (Table 2), which was somewhat similar to a study in Tehran, Iran, which showed the highest antibiotic resistance against co-trimoxazole, erythromycin, and tetracycline, respectively (17). The mec(A) gene was detected in 24% (6/25) and 43.5% (63/145) of isolates from outpatients and inpatients, respectively. In this study, a significant correlation (P < 0.05) was observed between the presence of the mec(A) gene and macrolide- and lincosamide-resistance genes in S. aureus isolates. In contrast to Schmitz et al., who reported that the macrolide-resistance gene was only detected in methicillin-susceptible S. aureus (MSSA) (18), our results showed that macrolide-resistance genes, including erm(A,B,C) and mrsA/B were associated with the mecA gene and MRSA isolates. These results suggested that there is probably a correlation between the mecA gene and others, such as macrolide-resistance genes, in S. aureus isolates in Kerman, Iran. Similar to other studies (3, 6), the MRSA isolates were resistant to five or more classes of antibiotics. According to some previous reports and our results, MRSA isolates are commonly resistant to many antibiotics, such as trimethoprim/sulfamethoxazole, aminoglycosides, and fluoroquinolones (6, 15, 16). In the present study, all isolates from both outpatients and inpatients were susceptible to vancomycin and linezolid; these results are in agreement with Zmantar et al. in Tunisia and with Navidinia and Shahmohammadi et al. in southwest Iran (6, 12, 17). Therefore, vancomycin and linezolid are still the most active agents against MRSA isolates. In contrast to our findings, in a study in Kerman, Iran by Shakibaie et al. prevalence of vancomycin intermediate resistant S. aureus 88.3% were reported by disk diffusion method, but according to CLSI guidelines, resistance to vancomycin must be screened with the agar dilution method, not the disk diffusion method. For this reason, Shakibaie et al.’s report is unreliable (4, 19). We found that the rate of resistance in is high in outpatient isolates. This finding supports the prediction that in the near future, many antibiotics, such as ciprofloxacin, trimethoprim-sulfamethoxazole, clindamycin, and erythromycin, will probably not be able to be used as agents for the empirical therapy of community-acquired infections. In the present study, 12.5% of isolates demonstrated inducible clindamycin resistance. In 2012, Mansouri et al. reported inducible clindamycin resistance in 8.64% of S. aureus isolates in Kerman. These results confirmed the increase of inducible clindamycin-resistance isolates to 12.5% in 2015 in Kerman (20). In this study, the resistance genes, including erm(A), erm(B), erm(C), and msr(A/B), were detected in 11%, 3.5%, 20.5%, and 10.5% of erythromycin and clindamycin-resistant isolates, respectively. These results were similar to those of Goudarzi et al. in Khorramabad, Iran (21). Also, the erm and msr genes have been reported in countries such as Denmark, the United Kingdom, and Tunisia (12). In Denmark and Tunisia, erm(A) and erm(B) were the most common erythromycin and clindamycin-resistance genes, respectively, but in our study, erm(C) was the most common. Erythromycin and clindamycin-resistant genes were not detected in 44 (46%) of the isolates that showed resistance to erythromycin and clindamycin in the present study, which is similar to Zmanter et al.’s investigation, which found no correlation between molecular and phenotypic methods for the detection of erythromycin and clindamycin resistance (12, 22, 23). This difference may be explained by the heterogeneous nature of erythromycin resistance, or it may be due to the loss of small plasmids that carry erm and msr genes (12, 22, 23).

5.1. Conclusion

The high prevalence of macrolide- and lincosamide-resistant genes found in isolates from nosocomial and community infections in Kerman, Iran, may be due to the transfer of resistance genes among isolates. As the macrolide-resistance genes are located on mobile genetic elements, horizontal transmission from resistant to susceptible isolates is unavoidable. Therefore, knowledge about susceptibility patterns may provide crucial information for controlling the dissemination of antimicrobial resistance.

Footnote

References

  • 1.

    Chaieb K, Zmantar T, Chehab O, Bouchami O, Ben Hasen A, Mahdouani K, et al. Antibiotic resistance genes detected by multiplex PCR assays in Staphylococcus epidermidis strains isolated from dialysis fluid and needles in a dialysis service. Jpn J Infect Dis. 2007; 60(4) : 183 -7 [PubMed]

  • 2.

    Rezaei M, Chavoshzadeh Z, Haroni N, Armin S, Navidinia M, Mansouri M, et al. Colonization With Methicillin Resistant and Methicillin Sensitive Staphylococcus aureus Subtypes in Patients With Atopic Dermatitis and Its Relationship With Severity of Eczema. Arch Pediatr Infect Dis. 2013; 1(2) : 5356 [DOI]

  • 3.

    Navidinia M. Detection of inducible clindamycin resistance (MLSBi) among methicillin-resistant Staphylococcus aureus (MRSA) isolated from health care providers. JPS. 2015; 6(1) : 91 -6

  • 4.

    Sadeghi J, Mansouri S. Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman). APMIS. 2014; 122(5) : 405 -11 [DOI][PubMed]

  • 5.

    Aghazadeh M, Ghotaslou R, Ahangarzadeh Rezaee M, Moshafi MH, Hojabri Z, Saffari F. Determination of antimicrobial resistance profile and inducible clindamycin resistance of coagulase negative staphylococci in pediatric patients: the first report from Iran. World J Pediatr. 2015; 11(3) : 250 -4 [DOI][PubMed]

  • 6.

    Navidinia M, Fallah F, Lajevardi B, Shirdoost M, Jamali J. Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolated From Health Care Providers in Mofid Children Hospital. Arch Pediatr Infect Dis. 2015; 3(2)[DOI]

  • 7.

    Performance Standards for Antimicrobial Susceptibility Testing,Twenty-First Informational Supplemen. 2015; 31 : 64 -70

  • 8.

    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3) : 268 -81 [DOI][PubMed]

  • 9.

    Performance Standards for Antimicrobial Susceptibility Testing, Twenty-First Informational Supplement. 2015; 31

  • 10.

    Emaneini M, Bigverdi R, Kalantar D, Soroush S, Jabalameli F, Noorazar Khoshgnab B, et al. Distribution of genes encoding tetracycline resistance and aminoglycoside modifying enzymes in Staphylococcus aureus strains isolated from a burn center. Ann Burns Fire Disasters. 2013; 26(2) : 76 -80 [PubMed]

  • 11.

    Emaneini M, Eslampour MA, Sedaghat H, Aligholi M, Jabalameli F, Shahsavan S, et al. Characterization of phenotypic and genotypic inducible macrolide resistance in staphylococci in Tehran, Iran. J Chemother. 2009; 21(5) : 595 -7 [DOI][PubMed]

  • 12.

    Zmantar T, Kouidhi B, Miladi H, Bakhrouf A. Detection of macrolide and disinfectant resistance genes in clinical Staphylococcus aureus and coagulase-negative staphylococci. BMC Res Notes. 2011; 4 : 453 [DOI][PubMed]

  • 13.

    Strommenger B, Kettlitz C, Werner G, Witte W. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 2003; 41(9) : 4089 -94 [PubMed]

  • 14.

    Singh KV, Malathum K, Murray BE. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother. 2001; 45(1) : 263 -6 [DOI][PubMed]

  • 15.

    Poorabbas B, Mardaneh J, Rezaei Z, Kalani M, Pouladfar G, Alami MH, et al. Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran. Iran J Microbiol. 2015; 7(3) : 127 -35 [PubMed]

  • 16.

    Hassanzadeh P, Hassanzadeh Y, Mardaneh J, Rezai E, Motamedifar M. Isolation of Methicillin-Resistant Staphylococcus aureus (MRSA) from HIV Patients Referring to HIV Referral Center, Shiraz, Iran, 2011-2012. Iran J Med Sci. 2015; 40(6) : 526 -30 [PubMed]

  • 17.

    Shahmohammadi MR, Nahaei MR, Akbarzadeh A, Milani M. Clinical test to detect mecA and antibiotic resistance in Staphylococcus aureus, based on novel biotechnological methods. Artif Cells Nanomed Biotechnol. 2015; : 1 -5 [DOI][PubMed]

  • 18.

    Schmitz FJ, Sadurski R, Kray A, Boos M, Geisel R, Kohrer K, et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother. 2000; 45(6) : 891 -4 [PubMed]

  • 19.

    Shakibaie M, Forootanfar H, Golkari Y, Mohammadi-Khorsand T, Shakibaie MR. Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J Trace Elem Med Biol. 2015; 29 : 235 -41 [DOI][PubMed]

  • 20.

    Mansouri S, Sadeghi J. Inducible Clindamycin Resistance in Methicillin-Resistant and-Susceptible Staphylococcus aureus Isolated From South East of Iran. Jundishapur J Microbiol. 2014; 7(12) : 11868 [DOI][PubMed]

  • 21.

    Goudarzi GR, Tahmasbi F, Anbari K, Ghafarzadeh M. The Prevalence of Macrolides-Resistant Genes Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran. Iran Red Crescent Med J. 2016; 18(2) : 25701 [DOI]

  • 22.

    Fluit AC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin Microbiol Rev. 2001; 14(4) : 836 -71 [DOI][PubMed]

  • 23.

    Zmantar T, Chaieb K, Ben Abdallah F, Ben Kahla-Nakbi A, Ben Hassen A, Mahdouani K, et al. Multiplex PCR detection of the antibiotic resistance genes in Staphylococcus aureus strains isolated from auricular infections. Folia Microbiol (Praha). 2008; 53(4) : 357 -62 [DOI][PubMed]

  • COMMENTS

    LEAVE A COMMENT HERE: